BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18663622)

  • 1. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.
    Dabbas S; Kaushik RR; Dandamudi S; Kuesters GM; Campbell RB
    Endothelium; 2008; 15(4):189-201. PubMed ID: 18663622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
    J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
    Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
    Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.
    Papagiannaros A; Hatziantoniou S; Dimas K; Papaioannou GT; Demetzos C
    Biomed Pharmacother; 2006 Jan; 60(1):36-42. PubMed ID: 16271845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
    Zhao W; Ma HL; Qi XR
    Yao Xue Xue Bao; 2007 Sep; 42(9):982-8. PubMed ID: 18050743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of vascular gene transfer using a novel cationic lipid.
    Matsumura JS; Kim R; Shively VP; MacDonald RC; Pearce WH
    J Surg Res; 1999 Aug; 85(2):339-45. PubMed ID: 10423338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro.
    Belting M; Petersson P
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):281-6. PubMed ID: 10455012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
    J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery.
    Rajesh M; Sen J; Srujan M; Mukherjee K; Sreedhar B; Chaudhuri A
    J Am Chem Soc; 2007 Sep; 129(37):11408-20. PubMed ID: 17718562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature.
    Dandamudi S; Campbell RB
    Biochim Biophys Acta; 2007 Mar; 1768(3):427-38. PubMed ID: 17258172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
    Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
    Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
    Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
    Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential binding of polyethylene glycol-coated liposomes containing a novel cationic lipid, TRX-20, to human subendthelial cells via chondroitin sulfate.
    Harigai T; Kondo M; Isozaki M; Kasukawa H; Hagiwara H; Uchiyama H; Kimura J
    Pharm Res; 2001 Sep; 18(9):1284-90. PubMed ID: 11683241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chain length on physicochemical properties and cytotoxicity of cationic vesicles composed of phosphatidylcholines and dialkyldimethylammonium bromides.
    Liang CH; Chou TH
    Chem Phys Lipids; 2009 Apr; 158(2):81-90. PubMed ID: 19428352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines.
    Díaz C; Vargas E; Gätjens-Boniche O
    Int J Pharm; 2006 Nov; 325(1-2):108-15. PubMed ID: 16870366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.